1731 related articles for article (PubMed ID: 19001018)
41. Combined partial exon skipping and cryptic splice site activation as a new molecular mechanism for recessive type 1 von Willebrand disease.
Gallinaro L; Sartorello F; Pontara E; Cattini MG; Bertomoro A; Bartoloni L; Pagnan A; Casonato A
Thromb Haemost; 2006 Dec; 96(6):711-6. PubMed ID: 17139363
[TBL] [Abstract][Full Text] [Related]
42. Insertion of a 5' truncated L1 element into the 3' end of exon 44 of the dystrophin gene resulted in skipping of the exon during splicing in a case of Duchenne muscular dystrophy.
Narita N; Nishio H; Kitoh Y; Ishikawa Y; Ishikawa Y; Minami R; Nakamura H; Matsuo M
J Clin Invest; 1993 May; 91(5):1862-7. PubMed ID: 8387534
[TBL] [Abstract][Full Text] [Related]
43. Identification of seven novel cryptic exons embedded in the dystrophin gene and characterization of 14 cryptic dystrophin exons.
Zhang Z; Habara Y; Nishiyama A; Oyazato Y; Yagi M; Takeshima Y; Matsuo M
J Hum Genet; 2007; 52(7):607-617. PubMed ID: 17579806
[TBL] [Abstract][Full Text] [Related]
44. Dystrophin expression in the mdx mouse after localised and systemic administration of a morpholino antisense oligonucleotide.
Fletcher S; Honeyman K; Fall AM; Harding PL; Johnsen RD; Wilton SD
J Gene Med; 2006 Feb; 8(2):207-16. PubMed ID: 16285002
[TBL] [Abstract][Full Text] [Related]
45. Familial adenomatous polyposis: aberrant splicing due to missense or silent mutations in the APC gene.
Aretz S; Uhlhaas S; Sun Y; Pagenstecher C; Mangold E; Caspari R; Möslein G; Schulmann K; Propping P; Friedl W
Hum Mutat; 2004 Nov; 24(5):370-80. PubMed ID: 15459959
[TBL] [Abstract][Full Text] [Related]
46. Bioinformatic and functional optimization of antisense phosphorodiamidate morpholino oligomers (PMOs) for therapeutic modulation of RNA splicing in muscle.
Popplewell LJ; Graham IR; Malerba A; Dickson G
Methods Mol Biol; 2011; 709():153-78. PubMed ID: 21194027
[TBL] [Abstract][Full Text] [Related]
47. DGGE-based whole-gene mutation scanning of the dystrophin gene in Duchenne and Becker muscular dystrophy patients.
Hofstra RM; Mulder IM; Vossen R; de Koning-Gans PA; Kraak M; Ginjaar IB; van der Hout AH; Bakker E; Buys CH; van Ommen GJ; van Essen AJ; den Dunnen JT
Hum Mutat; 2004 Jan; 23(1):57-66. PubMed ID: 14695533
[TBL] [Abstract][Full Text] [Related]
48. A strong exonic splicing enhancer in dystrophin exon 19 achieve proper splicing without an upstream polypyrimidine tract.
Habara Y; Doshita M; Hirozawa S; Yokono Y; Yagi M; Takeshima Y; Matsuo M
J Biochem; 2008 Mar; 143(3):303-10. PubMed ID: 18039686
[TBL] [Abstract][Full Text] [Related]
49. Abnormal splicing of hepatocyte nuclear factor 1 alpha in maturity-onset diabetes of the young.
Bulman MP; Harries LW; Hansen T; Shepherd M; Kelly WF; Hattersley AT; Ellard S
Diabetologia; 2002 Oct; 45(10):1463-7. PubMed ID: 12378390
[TBL] [Abstract][Full Text] [Related]
50. Characterization of a complex Duchenne muscular dystrophy-causing dystrophin gene inversion and restoration of the reading frame by induced exon skipping.
Madden HR; Fletcher S; Davis MR; Wilton SD
Hum Mutat; 2009 Jan; 30(1):22-8. PubMed ID: 18570328
[TBL] [Abstract][Full Text] [Related]
51. Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations.
Aartsma-Rus A; Fokkema I; Verschuuren J; Ginjaar I; van Deutekom J; van Ommen GJ; den Dunnen JT
Hum Mutat; 2009 Mar; 30(3):293-9. PubMed ID: 19156838
[TBL] [Abstract][Full Text] [Related]
52. A novel SLC12A3 splicing mutation skipping of two exons and preliminary screening for alternative splice variants in human kidney.
Shao L; Liu L; Miao Z; Ren H; Wang W; Lang Y; Yue S; Chen N
Am J Nephrol; 2008; 28(6):900-7. PubMed ID: 18580052
[TBL] [Abstract][Full Text] [Related]
53. Interplay between DMD point mutations and splicing signals in Dystrophinopathy phenotypes.
Juan-Mateu J; González-Quereda L; Rodríguez MJ; Verdura E; Lázaro K; Jou C; Nascimento A; Jiménez-Mallebrera C; Colomer J; Monges S; Lubieniecki F; Foncuberta ME; Pascual-Pascual SI; Molano J; Baiget M; Gallano P
PLoS One; 2013; 8(3):e59916. PubMed ID: 23536893
[TBL] [Abstract][Full Text] [Related]
54. Duchenne muscular dystrophy caused by a frame-shift mutation in the acceptor splice site of intron 26.
Meregalli M; Maciotta S; Angeloni V; Torrente Y
BMC Med Genet; 2016 Aug; 17(1):55. PubMed ID: 27515321
[TBL] [Abstract][Full Text] [Related]
55. Multiexon skipping leading to an artificial DMD protein lacking amino acids from exons 45 through 55 could rescue up to 63% of patients with Duchenne muscular dystrophy.
Béroud C; Tuffery-Giraud S; Matsuo M; Hamroun D; Humbertclaude V; Monnier N; Moizard MP; Voelckel MA; Calemard LM; Boisseau P; Blayau M; Philippe C; Cossée M; Pagès M; Rivier F; Danos O; Garcia L; Claustres M
Hum Mutat; 2007 Feb; 28(2):196-202. PubMed ID: 17041910
[TBL] [Abstract][Full Text] [Related]
56. Induced dystrophin exon skipping in human muscle explants.
McClorey G; Fall AM; Moulton HM; Iversen PL; Rasko JE; Ryan M; Fletcher S; Wilton SD
Neuromuscul Disord; 2006 Oct; 16(9-10):583-90. PubMed ID: 16919955
[TBL] [Abstract][Full Text] [Related]
57. Becker muscular dystrophy due to an intronic splicing mutation inducing a dual dystrophin transcript.
Todeschini A; Gualandi F; Trabanelli C; Armaroli A; Ravani A; Fanin M; Rota S; Bello L; Ferlini A; Pegoraro E; Padovani A; Filosto M
Neuromuscul Disord; 2016 Oct; 26(10):662-665. PubMed ID: 27616544
[TBL] [Abstract][Full Text] [Related]
58. Antisense-induced exon skipping for duplications in Duchenne muscular dystrophy.
Aartsma-Rus A; Janson AA; van Ommen GJ; van Deutekom JC
BMC Med Genet; 2007 Jul; 8():43. PubMed ID: 17612397
[TBL] [Abstract][Full Text] [Related]
59. [Comparison and analysis of the molecular character of breakpoints in introns of deletion hotspots of dystrophin gene].
Sheng WL; Chen JY; Pan SY; Zhang C; Liu ZL
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2003 Oct; 20(5):376-80. PubMed ID: 14556187
[TBL] [Abstract][Full Text] [Related]
60. Defective RNA splicing resulting from a mutation in the cyclic guanosine monophosphate-phosphodiesterase beta-subunit gene.
Piriev NI; Shih JM; Farber DB
Invest Ophthalmol Vis Sci; 1998 Mar; 39(3):463-70. PubMed ID: 9501854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
